Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Intercept Could Face Tougher Road To NASH Approval In EU Than US
Sep 30 2019
•
By
Joseph Haas
The busy pace continues in NASH as Intercept files an NDA; Galmed moves into Phase III
More from Approval Standards
More from Pathways & Standards